Kinex Pharmaceuticals, LLC and Hanmi Pharmaceutical Co., Ltd. announced today the execution of a license agreement from Hanmi Pharmaceuticals granting Kinex Pharmaceuticals
Kinex Pharmaceuticals has announced that its oncology drug, KX2-391, has entered a clinical trial entitled “A Phase Ib Rising Multiple-Dose Clinical Study